ISG12 is a critical modulator of innate immune responses in murine models of sepsis

Immunobiology

Volumn 218, Issue 9, 2013, Pages 1207-1216

  Uhrin, P ^a   Perkmann, T ^a   Binder, B ^a   Schabbauer, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Innate immunity; ISG12; Sepsis

Indexed keywords

CELL NUCLEUS RECEPTOR; ENVELOPE PROTEIN; INTERFERON STIMULATED GENE 12 PROTEIN; INTERLEUKIN 6; NUCLEAR RECEPTOR NUR77; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DOWN REGULATION; ENDOTOXEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; MALE; MORTALITY; MOUSE; NONHUMAN; NUCLEAR EXPORT SIGNAL; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEPSIS; SURVIVAL TIME;

INNATE IMMUNITY; ISG12; SEPSIS;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PROTEINS; SEPSIS;

EID: 84880043591     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.04.009     Document Type: Article

References (48)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
2. Annane D. Glucocorticoids in the treatment of severe sepsis and septic shock. Curr. Opin. Crit. Care 2005, 11:449-453.
3. Bani M.R., Nicoletti M.I., Alkharouf N.W., Ghilardi C., Petersen D., Erba E., Sausville E.A., Liu E.T., Giavazzi R. Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. Mol. Cancer Ther. 2004, 3:111-121.
4. Bieche I., Asselah T., Laurendeau I., Vidaud D., Degot C., Paradis V., Bedossa P., Valla D.C., Marcellin P., Vidaud M. Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005, 332:130-144.
5. Bonta P.I., Matlung H.L., Vos M., Peters S.L., Pannekoek H., Bakker E.N., de Vries C.J. Nuclear receptor Nur77 inhibits vascular outward remodelling and reduces macrophage accumulation and matrix metalloproteinase levels. Cardiovasc. Res. 2010, 87:561-568.
6. Bonta P.I., van Tiel C.M., Vos M., van Thienen J.V., Ferreira V., Arkenbout E.K., Seppen J., Spek C.A., van der P.T., Pannekoek H., de Vries C.J. Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses. Arterioscler. Thromb. Vasc. Biol. 2006.
7. Buras J.A., Holzmann B., Sitkovsky M. Animal models of sepsis: setting the stage. Nat. Rev. Drug Discov. 2005, 4:854-865.
8. Castrillo A., Tontonoz P. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu. Rev. Cell Dev. Biol. 2004, 20:455-480.
9. De B.K., Vanden B.W., Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 2003, 24:488-522.
10. Deng J.C., Cheng G., Newstead M.W., Zeng X., Kobayashi K., Flavell R.A., Standiford T.J. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 2006, 116:2532-2542.
11. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 1996, 384:39-43.
12. Docke W.D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., Volk H.D., Kox W. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 1997, 3:678-681.
13. Dooley T.P., Curto E.V., Reddy S.P., Davis R.L., Lambert G.W., Wilborn T.W., Elson C.O. Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays. Inflamm. Bowel Dis. 2004, 10:1-14.
14. Gjermandsen I.M., Justesen J., Martensen P.M. The interferon-induced gene ISG12 is regulated by various cytokines as the gene 6-16 in human cell lines. Cytokine 2000, 12:233-238.
15. Goodwin J.E., Feng Y., Velazquez H., Sessa W.C. Endothelial glucocorticoid receptor is required for protection against sepsis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:306-311.
16. Gruber F., Hufnagl P., Hofer-Warbinek R., Schmid J.A., Breuss J.M., Huber-Beckmann R., Lucerna M., Papac N., Harant H., Lindley I., de M.R., Binder B.R. Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha-induced PAI-1 expression. Blood 2003, 101:3042-3048.
17. Hanna R.N., Carlin L.M., Hubbeling H.G., Nackiewicz D., Green A.M., Punt J.A., Geissmann F., Hedrick C.C. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat. Immunol. 2011, 12:778-785.
18. Hanna R.N., Shaked I., Hubbeling H.G., Punt J.A., Wu R., Herrley E., Zaugg C., Pei H., Geissmann F., Ley K., Hedrick C.C. NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ. Res. 2012, 110:416-427.
19. Hatherill M., Tibby S.M., Turner C., Ratnavel N., Murdoch I.A. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit. Care Med. 2000, 28:2591-2594.
20. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138-150.
21. Hurley J.C. Concordance of endotoxemia with gram-negative bacteremia. A meta-analysis using receiver operating characteristic curves. Arch. Pathol. Lab. Med. 2000, 124:1157-1164.
22. Izmailova E., Bertley F.M., Huang Q., Makori N., Miller C.J., Young R.A., Aldovini A. HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages. Nat. Med. 2003, 9:191-197.
23. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391:82-86.
24. Lederer J.A., Rodrick M.L., Mannick J.A. The effects of injury on the adaptive immune response. Shock 1999, 11:153-159.
25. Malakhova O.A., Yan M., Malakhov M.P., Yuan Y., Ritchie K.J., Kim K.I., Peterson L.F., Shuai K., Zhang D.E. Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev. 2003, 17:455-460.
26. Martensen P.M., Justesen J. Small ISGs coming forward. J. Interferon Cytokine Res. 2004, 24:1-19.
27. Martensen P.M., Sogaard T.M., Gjermandsen I.M., Buttenschon H.N., Rossing A.B., Bonnevie-Nielsen V., Rosada C., Simonsen J.L., Justesen J. The interferon alpha induced protein ISG12 is localized to the nuclear membrane. Eur. J. Biochem. 2001, 268:5947-5954.
28. McKay L.I., Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 1999, 20:435-459.
29. Meakins J.L., Pietsch J.B., Bubenick O., Kelly R., Rode H., Gordon J., MacLean L.D. Delayed hypersensitivity: indicator of acquired failure of host defenses in sepsis and trauma. Ann. Surg. 1977, 186:241-250.
30. Nakagawa R., Naka T., Tsutsui H., Fujimoto M., Kimura A., Abe T., Seki E., Sato S., Takeuchi O., Takeda K., Akira S., Yamanishi K., Kawase I., Nakanishi K., Kishimoto T. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002, 17:677-687.
31. Oberholzer A., Oberholzer C., Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 2001, 16:83-96.
32. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 2005, 122:707-721.
33. Papac-Milicevic N., Breuss J.M., Zaujec J., Ryban L., Plyushch T., Wagner G.A., Fenzl S., Dremsek P., Cabaravdic M., Steiner M., Glass C.K., Binder C.J., Uhrin P., Binder B.R. The interferon stimulated gene 12 inactivates vasculoprotective functions of NR4A nuclear receptors. Circ. Res. 2012, 110:e50-e63.
34. Pei L., Castrillo A., Chen M., Hoffmann A., Tontonoz P. Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J. Biol. Chem. 2005, 280:29256-29262.
35. Pei L., Castrillo A., Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol. Endocrinol. 2006, 20:786-794.
36. Pires N.M., Pols T.W., de Vries M.R., van Tiel C.M., Bonta P.I., Vos M., Arkenbout E.K., Pannekoek H., Jukema J.W., Quax P.H., de Vries C.J. Activation of nuclear receptor Nur77 by 6-mercaptopurine protects against neointima formation. Circulation 2007, 115:493-500.
37. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat. Rev. Immunol. 2005, 5:375-386.
38. Qureshi S.T., Medzhitov R. Toll-like receptors and their role in experimental models of microbial infection. Genes Immun. 2003, 4:87-94.
39. Remick D.G., Bolgos G.R., Siddiqui J., Shin J., Nemzek J.A. Six at six: interleukin-6 measured 6h after the initiation of sepsis predicts mortality over 3 days. Shock 2002, 17:463-467.
40. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391:79-82.
41. Riedemann N.C., Guo R.F., Ward P.A. Novel strategies for the treatment of sepsis. Nat. Med. 2003, 9:517-524.
42. Ritchie K.J., Hahn C.S., Kim K.I., Yan M., Rosario D., Li L., de la Torre J.C., Zhang D.E. Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat. Med. 2004, 10:1374-1378.
43. Saijo K., Winner B., Carson C.T., Collier J.G., Boyer L., Rosenfeld M.G., Gage F.H., Glass C.K. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009, 137:47-59.
44. Schwab K., Witte D.P., Aronow B.J., Devarajan P., Potter S.S., Patterson L.T. Microarray analysis of focal segmental glomerulosclerosis. Am. J. Nephrol. 2004, 24:438-447.
45. Suomela S., Cao L., Bowcock A., Saarialho-Kere U. Interferon alpha-inducible protein 27 (IFI27) is upregulated in psoriatic skin and certain epithelial cancers. J. Invest. Dermatol. 2004, 122:717-721.
46. Thompson J., Winoto A. During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain. J. Exp. Med. 2008, 205:1029-1036.
47. Xiao H., Siddiqui J., Remick D.G. Mechanisms of mortality in early and late sepsis. Infect. Immun. 2006, 74:5227-5235.
48. Zantl N., Uebe A., Neumann B., Wagner H., Siewert J.R., Holzmann B., Heidecke C.D., Pfeffer K. Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis. Infect. Immun. 1998, 66:2300-2309.